Articles On Genetic Technologies (ASX:GTG)

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Molecular diagnostics company Genetic Technologies (ASX:GTG)  has announced the appointment of Michael Tonroe as its new chief financial officer.

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Summary ikeGPS (ASX:IKE) entered into a deal with Visual Globe’s AI platform to acquire its certain assets for the global communications and the electric utility market. The deal includes an initial payment of US$3.3 million in cash an...

04 Jan 2021 - Genetic Technologies (ASX:GTG) has appointed Simon Morriss to the role of Chief Executive Officer.

While genetic testing has gained immense popularity for its ability to diagnose monogenic mutations, experts believe that Polygenic Risk Score (PRS) is the future of predictive testing. Unlike genetic testing that captures only inherited di...

A quick wrap of the ASX’s key winners and losers on Tuesday, August 25. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 782 stocks rose, 682 declined and...

By Tim Boreham, Editor, The New Criterion The ASX biotechs surfing the COVID-19 story Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life sciences stocks across the d...

Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life science stocks across the drug, diagnostics and device sectors. Naturally, the biotechs drawing a connection with...

Summary The periodic return on a stock is the major determinator for an investor to make an investment in it, be it in the form of dividends or capital appreciation. In the last 3 months period, GTG has given a positive return of 100% t...

Mesoblast and Genetic Technologies renew investor interest with products fighting the virus.

A quick wrap of the ASX’s key winners and losers on Tuesday, July 21. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 1032 ASX stocks rose, 38...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the ASX’s key winners and losers on Thursday, July 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 604 stocks rose, 684 de...

One of the inconveniences of COVID-19 tests is that they can take several hours to complete. A number of ASX stocks are attempting to create faster tests, including two that surged this morning. AnteoTech Ltd (ASX:ADO), which said it has es...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the key winners and losers on Tuesday, June 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. The benchmark ASX200 Index bounced b...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

A quick wrap of the key winners and losers on Tuesday, June 2. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day.   Code Name Price % Chg...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Melbourne-based company Genetic Technologies (ASX:GTG) has updated on the development of its genetic test for the COVID-19 virus.

A vaccine for COVID-19 is expected to take a long time to develop and the company is confident its genetic test will be another bullet in the armoury to fight the virus in the meantime.

Dual-listed Genetic Technologies (ASX:GTG | NASDAQ: GENE) is fast-tracking development of a genetic test that will determine if people are at a high risk of contracting COVID-19. The company is to commence accelerating development of a poly...

Luck’s a fortune, eh? Atomo Diagnostics’ (ASX:AT1) ASX listing had been in the offing for months, based on its rapid blood-based diagnostic device for HIV that’s the only self-administered HIV assay approved by the local Therapeutic Goods A...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Molecular diagnostics company Genetic Technologies (ASX: GTG) has thrown its weight towards mitigating the effects of COVID-19 by drafting a “detailed implementation plan” that could see its genetic testing facilities transformed into a hig...

Today three more ASX small caps entered the fight against COVID-19 and all of them are notching share price gains. The candidates PharmAust (ASX:PAA), Harris Technology (ASX:HT8) and Genetic Technologies (ASX:GTG) all rose by at least 30 pe...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Yesterday, Stockhead reviewed the small caps that are devising treatments to fight cancer. There are also a handful of small caps that are seeking to help with diagnostics. In other words these small caps are either seeking to identify the...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 136-odd small cap health stocks, 47 saw their share prices fall, 67 improved and 22 were flat. >> Scroll down for a table showing the performance of s...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Genetic Technologies (ASX:GTG) shares doubled this morning after the company confirmed the US launch date for its latest breast cancer test. The company says the GeneType product will be released in the US commercially by the end of March....

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Australian health care sector is one of the fastest growing, dynamic and highly diversified sectors having enormous potential to generate substantial returns for the Australian economy. A broad range of companies, from companies engaged in...

Here’s our monthly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 92 saw their share prices fall, 32 improved and 13 were flat. >> Scroll down for a table showing the performance of small...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Technology certainly plays a significant role in each segment of the industry, more so than ever, and health care sector is no different. Introduction of technologies in the health care domain emerged as the biggest blessing not only for pa...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Last week it was former Hawthorn president Andrew Newbold who took a big leap of faith in his firm; this week it was former AFL commissioner Mike Fitzpatrick. He is on the board of Carnegie Clean Energy (ASX:CCE), which was finally recapita...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...